Literature DB >> 6893950

Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.

P P Sordillo, G B Magill, R J Gralla, R B Golbey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893950

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  2 in total

1.  Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).

Authors:  D J Stewart; G Zhengang; K Lu; N Savaraj; L G Feun; M Luna; R S Benjamin; M J Keating; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

2.  A phase II trial of m-AMSA in head and neck cancer.

Authors:  A A Forastiere; C W Young; R E Wittes
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.